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Supplemental oxygen reduces intimal hyperplasia
after intraarterial stenting in the rabbit
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Hypothesis: Supplemental oxygen can reduce intimal hyperplasia (IH) after stent deployment in a rabbit model.
Background: Endovascular stent placement is technically feasible, but long-term durability in vessels outside the aortoiliac
system is compromised with postinterventional IH, which causes restenosis and failure of the arterial conduit.
Methods: Groups (n 4 to 6) of female New Zealand white rabbits underwent placement of a 3-mm intraaortic stent with
laparotomy and were placed in either normoxic (21% inspired oxygen concentration) or supplemental-oxygen (40%
inspired oxygen concentration) environments for 0, 7, 14, and 28 days. The transarterial wall oxygen gradient was
measured at 0, 7, and 28 days with an oxygen microelectrode. 5-Bromo-2’deoxyuridine (BrdU) was injected into the
peritoneum before death to assess cellular proliferation. Aortic specimens were harvested en bloc and sectioned for
analysis of cellular proliferation and intimal thickness.
Results: Intraaortic stent placement significantly decreased the transarterial wall oxygen gradient in the outer 70% of the
vessel wall and was easily reversed at 7, 14, and 28 days with application of supplemental oxygen. Cellular proliferation
was significantly decreased at 14 days (0.5%  0.001% versus 2.3%  0.002%; P < .001) and 28 days (0.4%  0.001%
versus 1.0% 0.001%; P < .025) as measured with count of nuclei staining for 5-Bromo-2’deoxyuridine in the intima and
media. Intimal thickness was significantly decreased at 28 days in oxygen-supplemented rabbits (intimal area/medial
area  0.50  0.07) as compared with controls (intimal area/medial area  0.89  0.11; P < .025).
Conclusion: This study shows the ability of supplemental oxygen to reverse arterial wall hypoxia, decrease cellular
proliferation, and control IH at the deployment site of an intraarterial stent in a rabbit model. Forty-percent
supplemental oxygen suppresses IH by 44% at 28 days as compared with normoxic control values. Cellular proliferation
is reduced four-fold at 14 days and two-fold at 28 days in oxygen-supplemented rabbits as compared with control media
after deployment. The clinical implications of these findings are significant, especially as the role of endovascular
interventions continues to expand. (J Vasc Surg 2002;35:982-7.)
Postinterventional injury to arterial endothelium re-
sults in intimal hyperplasia (IH) and is common after
arterial interventions, including bypass grafting, endarter-
ectomy, angioplasty, and stent placement for atheroscle-
rotic occlusive or aneurysmal disease. Narrowing of the
arterial conduit ensues, which leads to ischemia. In the
clinical setting, the result may be infarction, stroke, limb
loss, and other end-organ damage.
Arterial stent placement and minimally invasive endo-
vascular techniques continue to gain popularity.1-4 Stent
placement is generally well-tolerated in large vessels, such
as the abdominal aorta and iliac arteries, but long-term
durability is often compromised by IH in smaller vessels,
such as coronary, carotid, and superficial femoral arteries.
Angiographic restenosis had been shown to be 25% to
31.6% at 6 months after coronary stent placement1,2 and
54.6% at 1 year after superficial femoral artery stent place-
ment.4
The histologic features of IH are well-defined and
begin with smooth muscle migration from the media to the
intima in response to arterial injury. Cellular proliferation
ensues, with elaboration of extracellular matrix and reste-
nosis.5,6 No widely accepted therapy exists at this time.
Much current research is directed at elucidation of the
mechanisms of intracellular and intercellular signaling and
regeneration pathways involved in the formation of IH.5,6
We have previously described the ability of a 40% supple-
mental oxygen environment to decrease IH at a prosthetic
graft to native artery anastomosis in the rabbit.7 Further, we
have shown that placement of an intraarterial stent alters
the transarterial wall oxygen gradient, inducing arterial wall
hypoxia.8 A method of controlling IH after stent deploy-
ment would allow for the expansion of endovascular ther-
apy to small diameter arteries.
The purpose of this study was to examine the effect of
supplemental oxygen after deployment of an intraarterial
stent. We hypothesized that application of supplemental
oxygen can reverse the transarterial wall oxygen gradient
after intraarterial stent deployment and that supplemental
oxygen can reduce IH after intraarterial stent deployment
in a rabbit model.
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Animal model. Female New Zealand white rabbits (2
to 3 kg; age, 9 to 12 months) from a single vendor were
allowed to acclimate for at least 3 days before interventions.
Rabbits were caged individually and fed standard chow and
water ad libitum. Animals were housed and cared for ac-
cording to an animal use protocol approved by the Minne-
apolis Veterans Affairs Medical Center Institutional Animal
Care and Use Committee and the University of Minnesota.
After placement of an intraarterial stent, rabbits were
randomly assigned to control (normoxic, 21% inspired
oxygen concentration) or treatment (supplemental oxygen,
40% inspired oxygen concentration) environments. The
treatment environment was maintained with the animals in
an oxygen chamber (Plas Laboratories, Lansing, Mich),
with constant monitoring of ambient atmospheric oxygen
concentration (40%) and humidity (50%). Oxygen-supple-
mented rabbits were removed to a normoxic environment
for brief periods daily (1 hour) for chamber maintenance,
including bedding, chow, and water changes. Thirty-six
animals in seven groups underwent measurement of
transarterial wall oxygen gradients, and another 35 animals
in seven groups underwent image analysis for assessment of
IH and cellular proliferation.
Placement of intraarterial stent. Rabbits underwent
anesthesia with ketamine hydrochloride (40 mg/kg) and
xylazine hydrochloride (5 mg/kg) intramuscularly and
were blindly intubated with a 3-mm endotracheal tube.
Anesthesia was maintained with passive isoflurane inhala-
tion (Abbott Laboratories, Chicago, Ill). Penicillin
(150,000 U) was administered intramuscularly. A 24-
gauge intravenous catheter was placed in a marginal ear
vein. With sterile technique, the infrarenal aorta was ex-
posed via midline laparotomy incision; proximal and distal
control were established below the renal arteries and above
the iliac bifurcation. Care was taken to preserve the vasa
vasorum. Heparin sulfate (800 U) was administered intra-
venously. A transverse aortotomy was created 5 mm above
the iliac bifurcation. Next, a 3-mm Palmaz-Schatz stainless
steel intraarterial stent (Cordis, Warren, NJ) was loaded
onto a 3-mm outer diameter with 2-cm long balloon
dilation catheter (Boston Scientific/Meditech, Watertown,
Mass) and inserted proximally via the aortotomy and de-
ployed below the renal arteries with balloon inflation to 3
atm for 30 seconds. The catheter was removed, and the
aortotomy was closed with 7-0 monofilament sutures.
Perioperative blood loss was replaced with intravenous
normal saline solution. Postoperative analgesia (buprenor-
phine, 0.05 mg/kg) was administered for 48 hours.
Transarterial wall oxygen gradient measurements.
After stent placement, animals were placed in the following
arms: 1, 0-day control (n 6); 2, 7-day control (n 5); 3,
28-day control (n  5); 4, 0-day treatment (n  5); 5,
7-day treatment (n 5); and 6, 28-day treatment (n 6);
for determination of transarterial wall oxygen gradients. An
additional control group (n  4) of 0-day, nonstented,
normoxic animals was analyzed. Briefly, with general anes-
thesia and via midline laparotomy, a previously calibrated
oxygen microelectrode was introduced into the midpoint
of the 3-mm infrarenal intraaortic stent at the adventitia
and advanced toward the lumen. Oxygen-supplemented
animals received 40% FiO2 during anesthesia, and control
animals received 21% FiO2. Measurements of artery wall
tissue oxygen level were recorded at 10-m increments
with a chemical microsensor (Model 1201; Diamond Gen-
eral Corp, Ann Arbor, Mich). Additional details regarding
construction and calibration of the electrode are described
elsewhere.9,10
Cellular proliferation. 5-Bromo-2’deoxyuridine (BrdU,
Zymed Laboratories, San Francisco, Calif) was used to assess
cellular proliferation. BrdU is incorporated into the nuclei of
dividing cells. Twenty-four hours before death, BrdU (100
mg/kg; Sigma Chemical Company, St Louis, Mo) was ad-
ministered via intraperitoneal injection.
Intraaortic stent harvest. Rabbits were killed with a
lethal injection of pentobarbital. The infrarenal aorta and
the infrarenal vena cava were cannulated with 20-gauge
catheters, and the animal was exsanguinated with normal
saline solution. Karnovsky’s solution was administered to
perfusion fix the aorta and intraaortic stent at 300 mm Hg
pressure for 10 minutes. Samples were harvested en bloc
and placed in formalin.
Specimen processing. Formalin-fixed specimens were
dehydrated in ascending grades of ethanol (70% to 100%)
at 37°C. After dehydration, the specimens were thoroughly
infiltrated in methyl methacrylate with a three-step proto-
col at 4°C in a vacuum chamber. After infiltration with
methyl methacrylate, the polymerization process was com-
pleted with placement of the specimens in a 37°C oven
until hardened. Cutting and grinding through the stented
portion of the aorta produced 30-m to 50-m ground
sections, which were stained with hematoxylin and eosin,
air dried, and coverslipped with acrylic mounting medium.
Four-m aortic cross sections were acquired 1 mm
distal to the stent for BrdU staining with the Zymed BrdU
staining kit. Sections were mounted on glass slides and
dried in a 60°C oven. The sections then were deparaffinized
in xylene and rehydrated with a series of ethanols. Endog-
enous peroxidase activity was attenuated in peroxidase
quenching solution, and the slides were rinsed in phospate-
buffered saline solution (PBS). Sections then were treated
with trypsin for 10 minutes in a moist chamber at 37°C,
followed by incubation with denaturing solution to in-
crease accessibility of antigen. Specimens were treated for
nonspecific labeling with blocking solution for 10 minutes.
Biotinylated mouse anti-BrdU reagent was applied for 60
minutes, followed by a rinse in PBS. Sections were incu-
bated for 10 minutes with streptavidin-peroxidase. After
rinsing, the color was developed with incubation with
3,3-diaminobenxidine mixture with the aid of a micro-
scope. Sections were counterstained with hematoxylin,
washed in a tap water, transferred into PBS until the nuclei
were blue, and then rinsed in distilled water. Slides were
dehydrated in graded alcohol solutions, cleared in xylene,
and coverslipped.
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Image analysis. Image analysis was carried out in a
blinded fashion. Specimens were analyzed for IH with a
microscope with a digitized camera attachment (Zeiss,
Oberkochen, Germany) feeding real time images to image
analysis software (Bioquant, R&M Biometrics, Nashville,
Tenn) on a personal computer. The digital camera was
calibrated with measurement of a known distance on the
microscope stage. Intimal and medial boundaries then were
marked, and intimal and medial areas were automatically
calculated. One proximal and one distal section were ob-
tained from each specimen. IH is reported as the ratio of
intimal area (IA) to medial area (MA), to standardize for
varying animal aortic sizes and extent of fixation.
Cellular proliferation was assessed at 1 mm distal to the
stent because the sectioning process for the stented aorta
was not compatible with the BrdU assay. Cellular prolifer-
ation was evaluated with image analysis software (Bio-
quant) to count cells with brown stained BrdU nuclei in the
intima and media of each specimen, at 1 mm distal to the
stent. This process was repeated to obtain a total count of
all cells in the intima and media. Cellular proliferation is
reported as the ratio of BrdU-stained cells to the total cell
count.
Statistical analysis. Transarterial wall oxygen gradi-
ents are expressed as mean  standard deviation. IH and
cellular proliferation data are expressed as mean standard
error of the mean. Student two-tailed t test was used to
compare transarterial wall oxygen gradients, IH, and cellu-
lar proliferation between rabbits with oxygen supplemen-
tation (treatment) and normoxic animals (controls) at vary-
ing time points. Normal distribution of the data was
determined and confirmed with kurtosis and skewness
tests. A P value less than .05 was considered significant.
RESULTS
Placement of an intraarterial stent resulted in immedi-
ate arterial wall hypoxia in the outer 70% of the vessel wall
as compared with nonstented controls (P .01; Fig 1) in a
normoxic (21% oxygen) setting. This effect was reversed
with application of 40% supplemental oxygen, where mean
tissue oxygen tensions were increased through the entire
artery wall (P  .001; Fig 2). Similarly, supplemental
oxygen increased the transarterial wall oxygen gradient in
7-day and 28-day oxygen-supplemented animals when
compared with normoxic controls (P .001; Fig 3). Nadir
values occurred at similar sites in each group, with 60% of
the vessel wall. In addition, day-0 oxygen-supplemented
rabbits had significantly lower transarterial wall oxygen
tensions in the outer 80% of the vessel wall (P  .025; Fig
3).
Cellular proliferation was decreased in oxygen-supple-
mented rabbits at 14 days as compared with normoxic
controls (0.5% 0.001% versus 2.3% 0.002%; P .001;
Figs 4 to 6). A similar effect was appreciated at 28 days,
where cellular proliferation was again decreased in the
oxygen-supplemented animals (0.4% 0.001% versus 1.0%
 0.001%; P  .025; Fig 7). Cellular proliferation was not
significantly different at 7 days.
IH was decreased in the oxygen-supplemented rabbits
(IA/MA  0.50  0.07; Table) as compared with nor-
moxic controls at 28 days (IA/MA  0.89  0.11; P 
.025). No difference in IA/MA was seen in 7-day or 14-day
arms. Histologic analysis results showed persistence of vasa
vasorum in the periadventitial tissue after stent deployment.
DISCUSSION
This study is the first published report to show the
ability of supplemental oxygen to reverse arterial wall hyp-
oxia, decrease cellular proliferation, and control IH at the
deployment site of an intraarterial stent in a rabbit model.
Forty-percent supplemental oxygen suppresses IH by 44%
at 28 days as compared with normoxic control values.
Cellular proliferation is reduced four-fold at 14 days and
two-fold at 28 days in oxygen-supplemented rabbits as
compared with controls. The clinical implications of these
findings are significant, especially as the role of endovascu-
lar interventions continues to expand.
Fig 1. Transarterial wall oxygen gradient for stented and nonstented normoxic day-0 rabbits (mean  standard
deviation). Measured partial pressure of oxygen (PO2) is significantly lower in stented rabbits in outer 70% of artery
wall.
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Delineation of the mechanism of IH formation sug-
gests multiple pathways, mediated by platelets, macro-
phages, and leukocytes, elaborating growth factors and
cytokines.5,6,11-13 However, we believe hypoxia should be
construed as an inciting event in the development of IH, a
signal for the biochemical cascade that characterizes the
pathobiology of IH. In these experiments, we were able to
show that transarterial wall oxygen profiles were signifi-
cantly diminished in the outer 70% of the vessel wall imme-
diately after placement of a stent and that this effect could
be easily and convincingly reversed with the application of
40% supplemental oxygen at normal atmospheric pressure.
Fig 2. Transarterial wall oxygen gradient for intraarterial stent day-0 rabbits, control versus oxygen-supplemented
(mean  standard deviation), with all values significantly different (P  .001). PO2, Partial pressure of oxygen.
Fig 3. Transarterial wall oxygen gradients for intraarterial stent day-7 and day-28 rabbits for control versus oxygen-
supplemented (mean standard deviation), with all supplemented values significantly higher than control values (P
.001). PO2, Partial pressure of oxygen.
Fig 4. Cellular proliferation as measured with ratio of cells with
positive staining results for BrdU to total cell count of intima and
media for 14-day control and oxygen-supplemented rabbits (P 
.001).
Fig 5. Cellular proliferation 1-mm distal to stent in 14-day con-
trol rabbit. Immunoperoxidase staining of BrdU-labeled cells.
Darkly stained nuclei (arrows) represent cells with positive staining
results. IEL, Internal elastic lamina (biotinylated mouse anti-
BrdU; original magnification, 200).
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The exact mechanism for the effect of a supranormal
transarterial wall oxygen gradient has not yet been delin-
eated. We hypothesize that the observed inhibition of IH
with supplemental oxygen is on the basis of reversal of
hypoxia and a reduction in oxidative stress in the vessel wall.
Stent deployment is known to decrease the transarterial
wall oxygen gradient.8 The increased circumferential and
radial stress associated with intraarterial stent deployment
decreases oxygen delivery and increases oxygen consump-
tion, inducing a hypoxic state.8 Percutaneous transluminal
coronary angioplasty has been shown to result in depletion
of glutathione levels14 and production of isoprostanes15;
both are indicative of increased oxidative stress. Oxidative
stress generates reactive oxygen species, such as the super-
oxide, hydroxyl, and hydrogen peroxide. Besides their
known effects of increased microvascular permeability and
tissue damage in models of ischemia/reperfusion and hy-
peroxia,16,17 reactive oxygen species can inactivate nitric
oxide, a molecule that regulates smooth muscle cell migra-
tion and proliferation.6,18,19
Potential shortcomings of this study should be ad-
dressed. The open model of stent placement does not
duplicate minimally invasive techniques used in humans,
but careful intraoperative dissection was performed to pre-
serve the periadventitial tissues and prevent disruption of
blood flow to the arterial wall. Evidence of the success of
this technique was borne out in histologic examination that
confirmed presence of vasa vasorum. This study was per-
formed on healthy rabbit aortas, which is in sharp contrast
to the most common clinical scenario of diseased athero-
sclerotic artery walls. Future studies should address the
efficacy of supplemental oxygen in an atherosclerotic
model. Oxygen toxicity may be seen at high levels of
inspired oxygen. The side effects of supplemental oxygen at
low levels seem minimal in man, provided concentrations
are kept below 50%.18,20 Rabbits in this study did not
appear to have adverse consequences from 1 month of a
40% supplemental oxygen environment. High levels of
supplemental oxygen (80%) have been shown to cause
adverse clinical consequences in humans, such as pulmo-
nary edema and retinopathy of prematurity and in vitro
cellular toxicity.16,18,20,21 Natural defense systems, such as
superoxide dismutase, catalase, and glutathione peroxidase,
may become overwhelmed, and indeed evidence for de-
creases in enzyme activity and increased reactive oxygen
levels have been shown at high levels of oxygen supplemen-
tation.20,22,23 Finally, we have shown a reduction of IH at
a short-term time point. Long-term outcomes after appli-
cation of supplemental oxygen will need to be evaluated in
a rabbit model. Ultimately, the effectiveness of supplemen-
tal oxygen will need to be assessed in human studies.
CONCLUSION
Stent durability in small vessels will continue to be
compromised until a dependable treatment for restenosis as
a result of IH is available. Administration of 40% supple-
mental oxygen creates a supraphysiologic hyperoxic state
and seems to counteract the hypoxic effect of stent deploy-
ment on the arterial wall, thereby attenuating IH forma-
tion. Supplemental oxygen represents a ubiquitous, safe,
inexpensive, and easily administered therapy. We have
shown a response to supplemental oxygen in the form of
decreased indices of IH early in the postinterventional
period.
Fig 6. Cellular proliferation 1-mm distal to stent in 14-day oxy-
gen-supplemented rabbit. Immunoperoxidase staining of BrdU-
labeled cells. Darkly stained nuclei (arrows) represent cells with
positive staining results. IEL, Internal elastic lamina (biotinylated
mouse anti-BrdU; original magnification, 200).
Fig 7. Cellular proliferation as measured with ratio of cells with
positive staining results for BrdU cells to total cell count of intima
and media for 28-day control and oxygen-supplemented rabbits
(P  .025).
Table I. IH: IA/MA
Control Oxygen-supplemented
0 day 0.01 ( 0.002)*
7 day 0.61 ( 0.21) 0.65 ( 15)
14 day 0.57 ( 0.09) 0.68 ( 0.17)
28 day 0.89 ( 0.11) 0.50 ( 0.07)†
*P  .05, control day 0 versus all other groups.
†P  .025, control versus oxygen-supplemented 28 days.
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